SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Shareholder Notice: Lawsuit Filed Against Takeover
September 06, 2017 at 12:45 PM EDT
San Diego, CA -- (SBWIRE) -- 09/06/2017 -- The Shareholders Foundation announces that an investor, who currently holds shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)), filed a lawsuit against the takeover of SciClone Pharmaceuticals, Inc. for $11.18 per share.
